Executive Director, Global Program Lead - Next Generation (Immunology & Cardiovascular)

Role Summary

Executive Director, Global Program Lead - Next Generation (Immunology & Cardiovascular) leads strategic development and execution of asset programs within the ICV Global Program Leadership organization, guiding cross-functional teams from late-stage discovery through commercialization to deliver high-quality, differentiated assets and maximize value.

Responsibilities

• Uses disease biology and drug development knowledge to create asset visions and design effective development programs aligned with overall R&D goals.
• Engages cross-company expertise and governance bodies to define and champion asset strategies and implementation plans.
• Analyzes progress, applies critical thinking, and drives data-driven decision making for assigned projects.
• Delivers high-quality assets suitable for commercialization with potential for strong patient impact and shareholder value.
• Ensures program standards are met within budget and schedule, while seeking continuous improvements without compromising quality.
• Communicates program risks and milestones to senior leaders and functional stakeholders; aligns plans with capabilities.
• Contributes to portfolio-level strategy for internal and external opportunities; participates in regulatory filings and orphan designation strategy.
• Leads development of program strategy, clinical plans, commercialization strategy, and business case development; informs trial design with access, pricing, and reimbursement considerations.
• Builds and maintains relationships with external stakeholders to maximize program impact.
• Manages clinical trial complexity from startup to readout; interprets data for scientific communication and commercial strategy.
• Incorporates market inputs into the development plan, including labeling considerations and forecast-related analyses.
• Supports investor relations and public affairs in external communications; integrates commercialization inputs for end-to-end program strategy.
• Collaborates with Medical Affairs on KOL plans and engagement; provides guidance on trade packaging and product considerations.
• Assesses risks, conducts valuations, and informs decision-making; contributes to brand strategy and non-clinical development considerations.

Qualifications

• MD, PhD, DVM, PharmD, MBA or equivalent with experience in drug development.
• 10+ years of experience in drug development and leadership in academic or industry settings.
• Expertise in drug development, matrix leadership, regulatory expectations, and commercialization.
• Proven ability to lead across global, cross-functional matrix organizations.
• Significant experience in immunology preferred; knowledge of basic biology, translational medicine, pharmacology, and dose selection.
• Strong understanding of regulatory requirements and commercialization impact; broad knowledge of exploratory development functions.
• Demonstrated ability to develop global strategies, prioritize initiatives, and drive data-driven acceleration.
• Proven ability to present complex programs to senior leaders and influence decisions; strong coaching and mentorship capabilities.
• Ability to multitask across multiple assets with complex strategies and accelerated timelines; effective cross-functional collaboration and business development input.

Skills

• Strategic thinking and problem-solving
• Cross-functional leadership and matrix management
• Regulatory and compliance navigation
• Clinical development planning and execution
• Commercialization strategy and market access insight
• Data interpretation and decision-making under uncertainty
• Stakeholder relationship management

Education

• MD, PhD, DVM, PharmD, MBA or equivalent advanced degree